Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903923 · ClinicalTrials.gov registry record
Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy
A clinical trial of Obesity and Bone Density, sponsored by University of Virginia.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06903923 is a study of Obesity and Bone Density that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06903923, a study of Obesity and Bone Density, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare bone health markers over 24 months in participants 12 - 21 years of age with obesity who are starting the glucagon-like peptide-1 (GLP-1) Semaglutide as compared to those with similar weight followed by lifestyle management. Participants will: * Take Semaglutide as prescribed or continue to work on lifestyle management for weight loss * Take provided calcium and vitamin D supplements * Attend 6 study visits over 24 months with two at the beginning and then every 6 months that include: * History and Physical Exams * Lab Work * Imaging studies * Questionnaires * 24-hour dietary recalls * Mixed Meal Tolerance Test with a nutritional energy drink and six blood draws
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Management
- DRUG GLP-1 receptor agonist
Study Locations (1)
Virginia
- University of Virginia Medical Center - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2031-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06903923
The ClinicalTrials.gov registry entry for NCT06903923 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Management is the first listed.
NCT06903923 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06903923 about?
NCT06903923 is a clinical study titled "Bone Metabolism in 12-21 Year Olds Undergoing GLP-1 Receptor Agonist Therapy". The goal of this clinical trial is to compare bone health markers over 24 months in participants 12 - 21 years of age with obesity who are starting the glucagon-like peptide-1 (GLP-1) Semaglutide as compared to those with similar weight followed by lifestyle management. Participants will: * Take S...
What is the current status of trial NCT06903923?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-06-01. Estimated completion is 2031-06-01.
What conditions does trial NCT06903923 study?
This clinical trial studies the following conditions: Obesity, Bone Density, GLP-1, Lifestyle Modification, Obesity in Children.
What interventions are being tested in trial NCT06903923?
The interventions under investigation include: Lifestyle Management (BEHAVIORAL), GLP-1 receptor agonist (DRUG).
Who is sponsoring clinical trial NCT06903923?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903923 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.